Back to search

Article

Proof-of-Concept in a Murine Model of Treatment of Thrombotic Thrombocytopenic Purpura Using Engineered Red Blood Cells

2025-06-15

Abstract excerpt

Thrombotic Thrombocytopenic Purpura (TTP) is caused by congenital or acquired deficiency of ADAMTS13, a metalloproteinase that cleaves von Willebrand Factor (vWF) multimers. Current treatments—plasma exchange and immunosuppression—are costly and associated with significant morbidity therefore, alternative strategies are needed. We developed the kitJak2 platform for producing genetically engineered lab-grown red bl...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ffebe426-b572-5db8-999c-09dc43ab6422
DOI
10.1101/2025.06.12.659386
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Proof-of-Concept in a Murine Model of Treatment of Thrombotic Thrombocytopenic Purpura Using Engineered Red Blood CellsDOI 10.1101/2025.06.12.659386
Select a neighboring publication to make it the new centre.